Statement |

MSF intervention on the Global Vaccine Action Plan at WHO 134th Executive Board meeting

Speaker: Dr Jennifer Cohn, Medical Director, MSF Access Campaign

134th WHO Executive Board meeting
Agenda item 6.2: Global Vaccine Action Plan

Médecins Sans Frontières welcomes the recommendations of the Strategic Advisory Group of Experts on the Global Vaccine Action Plan report. Improving the availability and quality of data on vaccination – as recommended in the Secretariat’s report - should indeed be a priority for the GVAP.

Currently, the only vaccine price data that is openly and publicly available on a systematic basis are the prices paid by the PAHO Revolving Fund and by UNICEF for GAVI-supported vaccines.  It is otherwise unclear what the majority of countries pay.

When the GVAP was adopted two years ago, several Member States raised concerns on the lack of vaccine price affordability and the extremely high prices paid by many middle income countries. Member States urged the GVAP Secretariat to play an active role in improving affordability so that all countries can benefit from life-saving vaccines. The cost of fully vaccinating a child has increased by 2,700 percent over the last decade, with a significant portion of the $51 billion dollar Decade of Vaccines allocated for the cost of the vaccines alone. It is critical that the cost of vaccines be monitored, particularly for countries that will lose GAVI support, and the middle income countries that increasingly cannot afford these high costs.

The SAGE recommendations to the GVAP Secretariat last November – on securing information on vaccine prices and improving the indicators for tracking vaccine affordability – should be implemented.

MSF urges the GVAP Secretariat to improve its role in the accurate and timely collection of vaccine price data. Member States should:

  • Report prices paid by the public sector for vaccines to the Secretariat agencies on an annual basis; and
  • Ensure the Secretariat is able to secure information on prices in self-procuring middle-income countries, high-income countries and the private market, in order to get a full and comprehensive picture of the global vaccine market and provide benchmark prices to enable comparisons and better procurement decisions.

Give All Children A Fair Shot

Join us in demanding a lower price
for pneumonia vaccine, and help save nearly
1 million children every year!